期刊文献+

人低氧诱导因子-1α重组腺病毒的构建和鉴定

Construction and identification of recombinant adenovirus carrying human hypoxia-inducible factor-1α gene
下载PDF
导出
摘要 目的利用AdMax腺病毒载体系统构建人重组低氧诱导因子-1α(rhHIF-1α)基因腺病毒并在293细胞中扩增制备重组病毒。方法自先期构建的pcDNA4-rhHIF-1α真核表达载体中用RT-PCR法扩增出rhHIF-1α基因片段,将其克隆入线性化的pEGFP1-C1质粒中,用PCR法扩增EGFP-rhHIF-1α基因片段,将其克隆入PUC18质粒中。酶切构建好的pUC18-rhHIF-1α载体并克隆进入穿梭质粒PDC316中,将构建好的穿梭质粒PDC316-rhHIF-1α载体和骨架病毒pBHGloxΔ1,3Cre共转染293细胞,包装成重组的病毒颗粒。重组的病毒转染SG-7901细胞,荧光显微镜观察绿色荧光表达。结果经限制性内切酶检测和GFP表达证实成功地构建了携带重组人HIF-1α基因的重组腺病毒载体并制备出高滴度重组病毒。结论成功地构建了携带rhHIF-1α基因片段的重组腺病毒载体。 Objective To construct the adenovirus vector carrying the recombinant human hypoxia-inducible factor-1 and amplify the adenovirus vector in 293 cells. Methods The recombinant human HIF-1α gene was obtained from constructed plasmid pc-DNA4-rhHIF-1α by RT-PCR and then inserted into linearized pEGFP-C1 plasmid. The EGFP-rhHIF-1α gene segment was amplified by RT-PCR from pEGFP-rhHIF-1α vector and cloned into the plasmid PUC18. After having been screened, the constructed pUC18- EGFP-rhHIF-1α plasmid was digested with restriction endonueleases and cloned into the shuttle plasmid PDC316 to form PDC316- rhHIF-1α vector. The PDC316-rhHIF-1α plasmid was cotransfected with genomic plasmid pBHGlox△1,3Cre into 293 cells to package the recombinant adenovirus. The recombinant adenovirus was transfected into SG-7901 cells, and the green fluorescence protein expression was detected. Results Recombinant adenoviral vector Ad-rhHIF-1α was constructed successfully, and confirmed by restriction enzyme digestion and GFP expression. Conclusion The recombinant adenoviral vector carrying rhHIF-1α can be successfully constructed.
出处 《山西医科大学学报》 CAS 2008年第11期965-968,共4页 Journal of Shanxi Medical University
关键词 腺病毒 血管再生 低氧诱导因子-1 缺血性疾病 adenovirus angiogenesis hypoxia-inducible factor-i ischemic disease
  • 相关文献

参考文献6

  • 1邱龄,肖传实,曾秋棠,李茂莲,王改玲,赵文燕.重组人HIF-1α真核表达载体质粒的构建和鉴定[J].山西医科大学学报,2005,36(5):523-527. 被引量:4
  • 2Semenza GL. Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1 [J]. Annu Rev Cell Dev Biol, 1999, 15:551 - 578.
  • 3Kallio PJ,Wilson WJ,O' Brien S, et al. Regulation of the hypoxiainducible transcription factor 1 alpha by the ubiquitin - proteasome pathway[ J ]. J Biol Chem, 1999,274 : 6519 - 6525.
  • 4Hirota K. Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression[J ]. J Anesth, 2002,16:150- 159.
  • 5Wang Yibin, Huang Shuang. Adenovirus technology for gene manipulation and functional studies [ J ]. Drug Discovery Today, 2000,5 : 10 - 16.
  • 6Freedman SB, Isner JM. Therapeutic angiogenesis for coronary artery disease[ J 1. Ann Intern Med, 2002,136 : 54.

二级参考文献12

  • 1Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1 [J]. Annu Rev Cell Dev Biol, 1999, 15:551 ~578.
  • 2Kallio PJ, Wilson WJ, O'Brien S, et al. Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin-proteasome pathway [J]. J Biol Chem, 1999, 274:6519~6525.
  • 3Hirota K. Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression [J]. J Anesth,2002,16 : 150~159.
  • 4Lee RJ, SpringerML, Blanco-BoseWE, etal. VEGFgenedelivery to myocardium: deleterious effects of unregulated expression [J]. Circulation, 2000,102: 898~901.
  • 5Schwartz Y, Kornowski R. Progenitor and embryonic stem cell transplantation for myocardial angiogenesis and functional restoration [J]. Eur Heart J,2003,24:404~411.
  • 6Springer ML, ChenAS, Kraft PE, etal. VEGF gene delivery to muscle: potential role of vasculogenesis in adults [ J ]. Mol Cell, 1998,2:549~ 558.
  • 7Schwariz JM, Kedes LH, Kloner RA, et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation [J]. J Am Coll Cardiol, 2000,35: 1323~1330.
  • 8Hariaxala M, Horowitz JR, Esakof D, et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts [J]. J Surg Res, 1996, 63:77~82.
  • 9Horowitz JR, Rivard A, van der Zee R, et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension[J ]. Arterioscler Thromb Vasc Biol, 1997, 17: 2793~2800.
  • 10Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 [J ].Science, 1999, 286:2511~2514.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部